Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2012
Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors
V M Macaulay, M R Middleton, A S Protheroe, et al.
The British Journal of Dermatology
|
July 17, 2013
Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study
P Lorigan, M Marples, M Harries, et al.
British Journal of Cancer
|
May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
O A Khan, A D Blann, M J Payne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma
B W Hancock, K Wheatley, S Harris, et al.
British Journal of Cancer
|
September 29, 2005
The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population
R O Illing, J E Kennedy, F Wu, et al.
Cancer Immunology, Immunotherapy : CII
|
May 21, 2022
Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies
V Moreno, E Calvo, M R Middleton, et al.
The British Journal of Radiology
|
June 19, 2008
High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response?
T A Leslie, J E Kennedy, R O Illing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 15, 2018
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial
V Urbonas, D Schadendorf, L Zimmer, et al.
British Journal of Cancer
|
April 16, 2009
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma
R F Kefford, N P B Thomas, P G Corrie, et al.
Journal of Medicinal Chemistry
|
December 19, 1998
Inactivation of O6-alkylguanine-DNA alkyltransferase. 1. Novel O6-(hetarylmethyl)guanines having basic rings in the side chain
R S McElhinney, D J Donnelly, J E McCormick, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2012
Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors
V M Macaulay, M R Middleton, A S Protheroe, et al.
The British Journal of Dermatology
|
July 17, 2013
Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study
P Lorigan, M Marples, M Harries, et al.
British Journal of Cancer
|
May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
O A Khan, A D Blann, M J Payne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma
B W Hancock, K Wheatley, S Harris, et al.
British Journal of Cancer
|
September 29, 2005
The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population
R O Illing, J E Kennedy, F Wu, et al.
Cancer Immunology, Immunotherapy : CII
|
May 21, 2022
Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies
V Moreno, E Calvo, M R Middleton, et al.
The British Journal of Radiology
|
June 19, 2008
High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response?
T A Leslie, J E Kennedy, R O Illing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 15, 2018
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial
V Urbonas, D Schadendorf, L Zimmer, et al.
British Journal of Cancer
|
April 16, 2009
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma
R F Kefford, N P B Thomas, P G Corrie, et al.
Journal of Medicinal Chemistry
|
December 19, 1998
Inactivation of O6-alkylguanine-DNA alkyltransferase. 1. Novel O6-(hetarylmethyl)guanines having basic rings in the side chain
R S McElhinney, D J Donnelly, J E McCormick, et al.
Page
of 6